Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1982 1
1983 1
1984 1
1985 2
1986 2
1987 5
1988 1
1991 3
1992 5
1993 2
1994 1
1995 5
1996 3
1997 1
1998 2
1999 2
2000 5
2001 7
2002 4
2003 2
2004 5
2005 5
2006 3
2007 6
2008 9
2009 8
2010 11
2011 6
2012 7
2013 17
2014 16
2015 16
2016 9
2017 11
2018 15
2019 12
2020 15
2021 25
2022 29
2023 15
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

271 results

Results by year

Filters applied: . Clear all
Page 1
Pronociceptive Roles of Schwann Cell-Derived Galectin-3 in Taxane-Induced Peripheral Neuropathy.
Koyanagi M, Imai S, Matsumoto M, Iguma Y, Kawaguchi-Sakita N, Kotake T, Iwamitsu Y, Ntogwa M, Hiraiwa R, Nagayasu K, Saigo M, Ogihara T, Yonezawa A, Omura T, Nakagawa S, Nakagawa T, Matsubara K. Koyanagi M, et al. Among authors: yonezawa a. Cancer Res. 2021 Apr 15;81(8):2207-2219. doi: 10.1158/0008-5472.CAN-20-2799. Epub 2021 Feb 19. Cancer Res. 2021. PMID: 33608316
Activation of AMP-activated protein kinase (AMPK) through inhibiting interaction with prohibitins.
Kanagaki S, Tsutsui Y, Kobayashi N, Komine T, Ito M, Akasaka Y, Nagasawa M, Ide T, Omae N, Nakao K, Rembutsu M, Iwago M, Yonezawa A, Hosokawa Y, Hosooka T, Ogawa W, Murakami K. Kanagaki S, et al. Among authors: yonezawa a. iScience. 2023 Feb 28;26(4):106293. doi: 10.1016/j.isci.2023.106293. eCollection 2023 Apr 21. iScience. 2023. PMID: 36950117 Free PMC article.
Chapter 3: Management of kidney injury caused by cancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022.
Ando Y, Nishiyama H, Shimodaira H, Takano N, Sakaida E, Matsumoto K, Nakanishi K, Sakai H, Tsukamoto S, Komine K, Yasuda Y, Kato T, Fujiwara Y, Koyama T, Kitamura H, Kuwabara T, Yonezawa A, Okumura Y, Yakushijin K, Nozawa K, Goto H, Matsubara T, Hoshino J, Yanagita M; Committee of Clinical Practice Guidelines for the Management of Kidney Disease During Anticancer Drug Therapy 2022. Ando Y, et al. Among authors: yonezawa a. Int J Clin Oncol. 2023 Oct;28(10):1315-1332. doi: 10.1007/s10147-023-02382-2. Epub 2023 Jul 16. Int J Clin Oncol. 2023. PMID: 37453935
Effects of combined test dose and therapeutic drug monitoring strategy in exposure-directed busulfan.
Iemura T, Kondo T, Ueda A, Maeda T, Kitawaki T, Arai Y, Kanda J, Ikeda T, Imada K, Ishikawa T, Anzai N, Itoh M, Takeoka T, Akasaka T, Yago K, Yonezawa A, Arima N, Kitano T, Nohgawa M, Watanabe M, Moriguchi T, Yamashita K, Ueda Y, Matsumoto K, Takaori-Kondo A. Iemura T, et al. Among authors: yonezawa a. Ann Hematol. 2023 Oct;102(10):2909-2922. doi: 10.1007/s00277-023-05209-2. Epub 2023 Apr 13. Ann Hematol. 2023. PMID: 37052663 Clinical Trial.
Boosting Cancer Immunotherapy with Anti-CD137 Antibody Therapy.
Yonezawa A, Dutt S, Chester C, Kim J, Kohrt HE. Yonezawa A, et al. Clin Cancer Res. 2015 Jul 15;21(14):3113-20. doi: 10.1158/1078-0432.CCR-15-0263. Epub 2015 Apr 23. Clin Cancer Res. 2015. PMID: 25908780 Free PMC article. Review.
New therapy for neuropathic pain.
Mizoguchi H, Watanabe C, Yonezawa A, Sakurada S. Mizoguchi H, et al. Among authors: yonezawa a. Int Rev Neurobiol. 2009;85:249-60. doi: 10.1016/S0074-7742(09)85019-8. Int Rev Neurobiol. 2009. PMID: 19607975 Review.
271 results